LNCR Posts Robust Results For Q4, Gains Market Share
Analysts at Jefferies & Co maintain their "buy" rating on Lincare Holdings (NASDAQ: LNCR), while raising their estimates for the company. The target price for LNCR has been raised from $40 to $46.
Lincare reported its Q4 EPS ahead of the consensus, driven by strong organic revenue growth and tight cost control. “LNCR continues to capture market share from competitors struggling under severe Medicare reimbursement reductions over the past few years… While LNCR remains focused on keeping tight cost controls in place, service levels have remained high, a key factor behind the company's market share gains,” the analysts add.
“Given the prospect of incremental market share gains and increased share buybacks NT, LNCR's valuation remains compelling,” the analysts mention. Jefferies & Co has raised its EPS estimate for FY10 from $2.12 to $2.43.
